The House Energy and Commerce Committee today announced a hearing before the Oversight and Investigations Subcommittee for Wednesday, October 11, 2017, at 10 a.m. in room 2123 of the Rayburn House Office Building. The hearing is entitled, “Examining How Covered Entities Utilize the 340B Drug Pricing Program.”

Continue reading on COA’s main website